GlassScriptPhysician profile
Christopher Federico
NPI 1881861433
$1,484.08
in general payments reported to CMS, 2019-2025
18 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.73 · 2020: $679 · 2021: $134 · 2022: $16.30 · 2023: $257 · 2024: $202 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $600.00 | 2020 | |
| Abbvie INC. | $146.26 | 2019-2023 | |
| Exeltis, USA INC. | $96.07 | 2021-2025 | Slynd |
| Pfizer INC. | $94.25 | 2023-2024 | |
| Channel Medsystems, INC. | $68.65 | 2023 | |
| Organon LLC | $65.92 | 2023-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $58.56 | 2023-2025 | Veozah |
| Biogen, INC. | $49.83 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $39.82 | 2021-2023 | Paragard T 380a |
| Avion Pharmaceuticals | $37.66 | 2021 | |
| Mylan Pharmaceuticals INC. | $37.11 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $35.04 | 2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $34.99 | 2021-2022 | |
| Amgen INC. | $32.32 | 2023-2024 | Prolia, Evenity |
| Lupin INC. | $31.05 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $28.82 | 2025 | |
| Merck Sharp & Dohme LLC | $14.49 | 2024 | Gardasil, Gardasil 9 |
| Ascend Therapeutics US, LLC | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Federico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.